Sign in

CIK 0001453687

  • Non-accelerated filer
  • Smaller reporting company

Cartesian Therapeutics, Inc.

Sign in to watch
Ticker
RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-348-8698
Business address
7495 NEW HORIZON WAY, FREDERICK, MD, 21703
Former names
SELECTA BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-05 Johnston Lloyd P. Chief Operations Officer Sale −3,372 $1.13 $4K 265,535
2023-01-05 Johnston Lloyd P. Chief Operations Officer Sale −20 $1.11 $22 265,515
2023-01-05 Kishimoto Takashi Kei Chief Scientific Officer Sale −3,372 $1.13 $4K 364,336
2023-01-05 Kishimoto Takashi Kei Chief Scientific Officer Sale −20 $1.11 $22 364,316
2023-01-05 TRABER PETER G Chief Medical Officer Sale −3,445 $1.13 $4K 446,141
2023-01-05 TRABER PETER G Chief Medical Officer Sale −20 $1.11 $22 446,121
2023-01-04 Brunn Carsten President and CEO Sale −27,549 $1.13 $31K 799,534
2023-01-04 Brunn Carsten President and CEO Sale −48 $1.15 $55 799,486
2023-01-04 Johnston Lloyd P. Chief Operations Officer Sale −6,381 $1.13 $7K 268,918
2023-01-04 Johnston Lloyd P. Chief Operations Officer Sale −11 $1.14 $13 268,907
2023-01-04 Kishimoto Takashi Kei Chief Scientific Officer Sale −6,381 $1.13 $7K 367,719
2023-01-04 Kishimoto Takashi Kei Chief Scientific Officer Sale −11 $1.15 $13 367,708
2023-01-04 TRABER PETER G Chief Medical Officer Sale −8,164 $1.13 $9K 449,601
2023-01-04 TRABER PETER G Chief Medical Officer Sale −15 $1.14 $17 449,586
2023-01-02 Myers Scott Dunseth Director Grant or award · Stock Option (Right to Buy) +87,500 87,500
2023-01-02 ANDO GORAN Director Grant or award · Stock Option (Right to Buy) +75,000 75,000
2023-01-02 BARABE TIMOTHY C Director Grant or award · Stock Option (Right to Buy) +87,500 87,500
2023-01-02 Brunn Carsten President and CEO Grant or award +282,800 827,083
2023-01-02 Brunn Carsten President and CEO Grant or award · Employee Stock Option (right to buy) +1,275,000 1,275,000
2023-01-02 COX CARRIE SMITH Director Grant or award · Stock Option (Right to Buy) +107,500 107,500

Page 19 of 25 · 495 trades